These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26711719)

  • 21. Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes.
    Hällsten K; Virtanen KA; Lönnqvist F; Sipilä H; Oksanen A; Viljanen T; Rönnemaa T; Viikari J; Knuuti J; Nuutila P
    Diabetes; 2002 Dec; 51(12):3479-85. PubMed ID: 12453903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimal effect of walking before dinner on glycemic responses in type 2 diabetes: outcomes from the multi-site E-PAraDiGM study.
    Rees JL; Chang CR; François ME; Marcotte-Chénard A; Fontvieille A; Klaprat ND; Dyck RA; Funk DR; Snydmiller G; Bastell K; Godkin FE; Dubé MC; Riesco E; McGavock JM; Yardley JE; Sigal RJ; Gibala MJ; Weisnagel SJ; Prado CM; Jung M; Manders R; Lee T; Singer J; Boulé NG; Little JP
    Acta Diabetol; 2019 Jul; 56(7):755-765. PubMed ID: 31093764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide and metformin on pancreatic β-cell and insulin sensitivity during a standardized test meal in patients with type 2 diabetes.
    Mari A; Del Prato S; Ludvik B; Milicevic Z; de la Peña A; Shurzinske L; Karanikas CA; Pechtner V
    Diabetes Obes Metab; 2016 Aug; 18(8):834-9. PubMed ID: 27059816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes.
    Gastaldelli A; Nauck MA; Balena R
    Metabolism; 2013 Sep; 62(9):1330-9. PubMed ID: 23831441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycemic Efficacy and Metabolic Consequences of an Empagliflozin Add-on versus Conventional Dose-Increasing Strategy in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea.
    Shin Y; Moon JH; Chin HJ; Ferrannini E; Lim S
    Endocrinol Metab (Seoul); 2020 Jun; 35(2):329-338. PubMed ID: 32615717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of moderate exercise for 30 min at 30 min versus 60 min after dinner on glycemic control in patients with type 2 diabetes: a randomized, crossover, self-controlled study].
    Li Z; Hu Y; Ma J
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1165-1170. PubMed ID: 30377118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of lixisenatide once-daily morning or evening injections in type 2 diabetes inadequately controlled on metformin (GetGoal-M).
    Ahrén B; Leguizamo Dimas A; Miossec P; Saubadu S; Aronson R
    Diabetes Care; 2013 Sep; 36(9):2543-50. PubMed ID: 23536584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise improves metformin 72-h glucose control by reducing the frequency of hyperglycemic peaks.
    Ortega JF; Morales-Palomo F; Ramirez-Jimenez M; Moreno-Cabañas A; Mora-Rodríguez R
    Acta Diabetol; 2020 Jun; 57(6):715-723. PubMed ID: 32020414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One bout of exercise alters free-living postprandial glycemia in type 2 diabetes.
    Oberlin DJ; Mikus CR; Kearney ML; Hinton PS; Manrique C; Leidy HJ; Kanaley JA; Rector RS; Thyfault JP
    Med Sci Sports Exerc; 2014 Feb; 46(2):232-8. PubMed ID: 23872939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin and exercise in type 2 diabetes: examining treatment modality interactions.
    Boulé NG; Robert C; Bell GJ; Johnson ST; Bell RC; Lewanczuk RZ; Gabr RQ; Brocks DR
    Diabetes Care; 2011 Jul; 34(7):1469-74. PubMed ID: 21602430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The incretin mimetic exenatide as a monotherapy in patients with type 2 diabetes.
    Nelson P; Poon T; Guan X; Schnabel C; Wintle M; Fineman M
    Diabetes Technol Ther; 2007 Aug; 9(4):317-26. PubMed ID: 17705687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes.
    Garber AJ; Donovan DS; Dandona P; Bruce S; Park JS
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3598-604. PubMed ID: 12915642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fasting May Alter Blood Glucose Responses to High-Intensity Interval Exercise in Adults With Type 1 Diabetes: A Randomized, Acute Crossover Study.
    Yardley JE
    Can J Diabetes; 2020 Dec; 44(8):727-733. PubMed ID: 33160882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes.
    Rosenstock J; Brown A; Fischer J; Jain A; Littlejohn T; Nadeau D; Sussman A; Taylor T; Krol A; Magner J
    Diabetes Care; 1998 Dec; 21(12):2050-5. PubMed ID: 9839093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of the effects of a dipeptidyl peptidase-IV inhibitor and sulfonylurea on glucose variability in patients with type 2 diabetes with inadequate glycemic control on metformin.
    Kim HS; Shin JA; Lee SH; Kim ES; Cho JH; Son HY; Yoon KH
    Diabetes Technol Ther; 2013 Oct; 15(10):810-6. PubMed ID: 24050737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes.
    Malone JK; Bai S; Campaigne BN; Reviriego J; Augendre-Ferrante B
    Diabet Med; 2005 Apr; 22(4):374-81. PubMed ID: 15787659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of aerobic exercise with or without metformin on plasma incretins in type 2 diabetes.
    Eshghi SR; Bell GJ; Boulé NG
    Can J Diabetes; 2013 Dec; 37(6):375-80. PubMed ID: 24321717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sequential treatment with insulin glargine and metformin, and exenatide in a patient with newly diagnosed type-2 diabetes].
    Kress S
    Dtsch Med Wochenschr; 2010 May; 135(18):907-10. PubMed ID: 20425675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Durability of efficacy and long-term safety profile of glyburide/metformin tablets in patients with type 2 diabetes mellitus: an open-label extension study.
    Garber AJ; Bruce S; Fiedorek FT
    Clin Ther; 2002 Sep; 24(9):1401-13. PubMed ID: 12380632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.